+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Infinity Pharmaceuticals Inc (INFI) - Financial and Strategic SWOT Analysis Review

  • ID: 1292071
  • SWOT Analysis
  • 46 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Acerta Pharma BV
  • Bristol-Myers Squibb Co
  • Gilead Sciences Inc
  • GlaxoSmithKline Inc
  • Incyte Corp
  • Pfizer Inc
  • MORE
Infinity Pharmaceuticals Inc (INFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Critical Information Included:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Infinity Pharmaceuticals Inc (Infinity Pharmaceuticals) is a biopharmaceutical company that discovers and develops small molecule therapeutics for the treatment of cancer. The company’s pipeline candidate: IPI-549 selectively inhibits PI3K-gamma to reprogram tumor-associated macrophages and transforms immuno-oncology approach. It is evaluating IPI-549 as a monotherapy in Phase 2 clinical trials for the treatment of a wide range of solid tumors. Infinity Pharmaceuticals is also investigating IPI-549 in Phase 1 clinical studies for the treatment of advanced solid tumors, and in a combination therapy in Phase 1n clinical trials for the treatment of non-small cell lung cancer (NSCLC), melanoma, squamous cell carcinoma of the head and neck (SCCHN), triple negative breast cancer (TNBC), mesothelioma, adrenocortical carcinoma, and myeloid-derived suppressor cells (MDSC). Infinity Pharmaceuticals is headquartered in Cambridge, Massachusetts, the US.

Infinity Pharmaceuticals Inc Key Recent Developments

Mar 14, 2019 Infinity Pharmaceuticals reports full year 2018 financial results and provides company update
Nov 07, 2018 Bristol-Myers and Infinity partner for trial of opdivo and IPI-549
Nov 05, 2018 Infinity Pharmaceuticals announces third quarter 2018 financial results
Aug 07, 2018 Infinity Pharmaceuticals provides company update and second quarter 2018 financial results

Key Benefits Include

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Acerta Pharma BV
  • Bristol-Myers Squibb Co
  • Gilead Sciences Inc
  • GlaxoSmithKline Inc
  • Incyte Corp
  • Pfizer Inc
  • MORE
Section 1 - About the Company
  • Infinity Pharmaceuticals Inc - Key Facts
  • Infinity Pharmaceuticals Inc - Key Employees
  • Infinity Pharmaceuticals Inc - Key Employee Biographies
  • Infinity Pharmaceuticals Inc - Major Products and Services
  • Infinity Pharmaceuticals Inc - History
  • Infinity Pharmaceuticals Inc - Company Statement
  • Infinity Pharmaceuticals Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Infinity Pharmaceuticals Inc - Business Description
  • R&D Overview
  • Infinity Pharmaceuticals Inc - Corporate Strategy
  • Infinity Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Infinity Pharmaceuticals Inc - Strengths
  • Infinity Pharmaceuticals Inc - Weaknesses
  • Infinity Pharmaceuticals Inc - Opportunities
  • Infinity Pharmaceuticals Inc - Threats
  • Infinity Pharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Infinity Pharmaceuticals Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 14, 2019: Infinity Pharmaceuticals reports full year 2018 financial results and provides company update
  • Nov 07, 2018: Bristol-Myers and Infinity partner for trial of opdivo and IPI-549
  • Nov 05, 2018: Infinity Pharmaceuticals announces third quarter 2018 financial results
  • Aug 07, 2018: Infinity Pharmaceuticals provides company update and second quarter 2018 financial results
  • Aug 07, 2018: Infinity Pharmaceuticals appoints Samuel Agresta as Chief Medical Officer
  • May 08, 2018: Infinity Pharmaceuticals Provides Company Update and First Quarter 2018 Financial Results
  • Mar 08, 2018: Infinity Pharmaceuticals Announces Additions to Board of Directors and Clinical Leadership Team and Establishes Scientific Advisory Board
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Author
  • Contact Us
  • Disclaimer
List of Tables
  • Infinity Pharmaceuticals Inc, Key Facts
  • Infinity Pharmaceuticals Inc, Key Employees
  • Infinity Pharmaceuticals Inc, Key Employee Biographies
  • Infinity Pharmaceuticals Inc, Major Products and Services
  • Infinity Pharmaceuticals Inc, History
  • Infinity Pharmaceuticals Inc, Subsidiaries
  • Infinity Pharmaceuticals Inc, Key Competitors
  • Infinity Pharmaceuticals Inc, Ratios based on current share price
  • Infinity Pharmaceuticals Inc, Annual Ratios
  • Infinity Pharmaceuticals Inc, Interim Ratios
  • Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Infinity Pharmaceuticals Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Infinity Pharmaceuticals Inc, Performance Chart (2014 - 2018)
  • Infinity Pharmaceuticals Inc, Ratio Charts
  • Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • TG Therapeutics Inc
  • Pfizer Inc
  • Johnson & Johnson Consumer Inc
  • Incyte Corp
  • GlaxoSmithKline Inc
  • Gilead Sciences Inc
  • Bristol-Myers Squibb Co
  • Acerta Pharma BV
Note: Product cover images may vary from those shown
Adroll
adroll